UL
Ultralife Corporation
ULBI · NASDAQ
$5.58 +0.63% (+$0.04)
1M -23.35%
Market Cap $90.8M
P/E Ratio -
Div. Yield -
ROE 4.95%
Bulios Fair Price
$4.93
11.6% downside
Current Price
$5.58
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ULBI is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
54 /100
Fair P/B 0.69x
P/FCF 44.70x
P/S 0.48x
Growth
72 /100
Growing Book val. growth 3.79%
Rev. growth 13.18%
FCF growth N/A
Profitability
15 /100
Weak Net margin 3.50%
Op. margin 2.69%
FCF margin 1.08%
Quality
13 /100
Poor ROE 4.95%
ROA 3.03%
Asset turnover 0.87x
Debt
67 /100
Low Current ratio 2.87x
Int. coverage -1.65x
Debt/Equity 0.36x
Stability
55 /100
Moderate Rev. volatility 8.69%
EPS volatility 3,551.14%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ULBI
Online
Sector
Industrials
Industry
Electrical Equipment & Parts
CEO
Michael E. Manna
Employees
678
Headquarters
Newark
Upcoming events
09 NOV
Earnings
Upcoming earnings report